Please assess the completion status of the following clinical trial:

Trial Title: Effect of Preemptive Etoricoxib and Dexamethasone on Wound Healing and Clinical Parameters After Third Molar Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Systemically healthy individuals (ASA I by American Society of Anesthesiologists classification);~* Age 18-30 years;~* Absence of hypersensitivity to any of the medications in the study;~* Subjects capable to understand the protocol and sign an informed consent form.~Exclusion Criteria:~* Systemic disorders;~* Individuals in gestation or lactation period;~* Radiographic presence of potential cystic or tumorous lesions in the region of the extraction-required IMTM;~* Any symptoms or clinical signs of the infection caused by the extraction-required IMTM up to 10 days preoperatively;~* Use of NSAIDs or corticosteroids within 10 days before the surgery.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 30 Years
- Healthy Volunteers: t

Study Arms:
- Etoricoxib group (Type: ACTIVE_COMPARATOR): One hour preoperatively, preemptive, single-dose etoricoxib tablet in dosage of 90 mg will be administered orally
- Dexamethasone group (Type: ACTIVE_COMPARATOR): One hour preoperatively, preemptive, single-dose dexamethasone in dosage of 4 mg will be administered intramuscularly
- Control group (Type: NO_INTERVENTION): In this group, one hour preoperatively no medication will be administered

Based on this trial design, predict the completion outcome and termination type (if applicable).